PE-Linked Polyclonal Antibody to Catenin Beta 1 (CTNNb1)

Référence MBS2050648-0,2mL

Conditionnement : 0.2mL

Marque : MyBiosource

Contactez votre distributeur local :


Téléphone : +1 850 650 7790

Catenin Beta 1 (CTNNb1) Antibody – Rabbit Polyclonal

For Research Use Only. Not for use in diagnostic procedures. Special Promotion Catalog #: MBS2050648
SPECIAL PROMOTION: Get FREE Starbucks gift card (Maximum 5 gift cards/product). Gift card(s) will be included with shipment

MBS2050648 is an antibody targeting CTNNb1. Also known as PE-Linked Polyclonal Antibody to Catenin Beta 1 (CTNNb1). Reactive in Mouse, Human, Dog, Horse. Host: Rabbit. More details

Product Overview

Online Datasheet in PDF
Product Name
Catenin Beta 1 (CTNNb1), Polyclonal Antibody
Full Product Name
PE-Linked Polyclonal Antibody to Catenin Beta 1 (CTNNb1)
Product Gene Name
anti-CTNNb1 antibody
Product Synonym Names
bCat; b-Cat; CTNN-B1; Cadherin-Associated Protein
Clonality
Polyclonal
Host
Rabbit
Species Reactivity
Mouse, Human, Dog, Horse
Concentration
>=100ug/ml (lot specific)
Matching Pairs
Unconjugated Antibody: CTNNb1 (MBS2002391)
PE Conjugated Antibody: CTNNb1 (MBS2050648)
Matching Pairs
PE Conjugated Antibody: CTNNb1 (MBS2050648)
Immunogen: CTNNb1 (MBS2009090)
Molecular Weight
9,501 Da
OMIM
X87838 mRNA
Supply Chain Verification
Manufactured in a lab with traceable raw materials. Bulk orders can typically be prepared to the customer’s specifications, please inquire.
Immunogen
CTNNb1 (Lys508~Leu762)
Conjugation
PE
Cross Reactivity
Mouse
Unconjugated Antibody
The unconjugated antibody version of this item is also available as catalog #MBS2002391
ISO Certification
Manufactured in an ISO 9001:2015 and ISO 13485:2016 Certified Laboratory.
Applications Tested/Suitable for anti-CTNNb1 antibody
Western Blot (WB), Immunocytochemistry (ICC), Immunohistochemistry (IHC) Formalin/Paraffin, ELISA (ELISA)

Other Notes

Small volumes of anti-CTNNb1 antibody vial(s) may occasionally become entrapped in the seal of the product vial during shipment and storage. If necessary, briefly centrifuge the vial on a tabletop centrifuge to dislodge any liquid in the container`s cap. Certain products may require to ship with dry ice and additional dry ice fee may apply.

Additional Details

NCBI/Uniprot data below describe general gene information for CTNNb1. It may not necessarily be applicable to this product.

NCBI GI #
NCBI GeneID
NCBI Accession #
UniProt Secondary Accession #
UniProt Related Accession #
NCBI Official Full Name
catenin beta 1
NCBI Official Synonym Full Names
catenin beta 1
NCBI Official Symbol
CTNNB1
NCBI Official Synonym Symbols
CTNNB; MRD19; armadillo
UniProt Protein Name
Catenin beta-1
UniProt Synonym Protein Names
Beta-catenin
Protein Family
Catenin
UniProt Gene Name
CTNNB1
UniProt Synonym Gene Names
CTNNB
NCBI Protein Information
catenin beta-1

NCBI Summary for CTNNb1

The protein encoded by this gene is part of a complex of proteins that constitute adherens junctions (AJs). AJs are necessary for the creation and maintenance of epithelial cell layers by regulating cell growth and adhesion between cells. The encoded protein also anchors the actin cytoskeleton and may be responsible for transmitting the contact inhibition signal that causes cells to stop dividing once the epithelial sheet is complete. Finally, this protein binds to the product of the APC gene, which is mutated in adenomatous polyposis of the colon. Mutations in this gene are a cause of colorectal cancer (CRC), pilomatrixoma (PTR), medulloblastoma (MDB), and ovarian cancer. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Aug 2016]
Show more

UniProt Comments for CTNNb1

CTNNB1: a regulator of cell adhesion and a key downstream effector in the Wnt signaling pathway. Implicated early embryonic development and tumorigenesis. Phosphorylated and destabilized by CK1 and GSK-3beta. Stabilized cytoplasmic beta-catenin is a hallmark of a variety of cancers. Stabilized beta-catenin translocates to the nucleus, where it acts as a transcriptional activator of T-cell factor (TCF)-regulated genes. Interacts with the PDZ domain of TAX1BP3, inhibiting its transcriptional activity. Two alternatively spliced human isoforms have been described.

Protein type: Actin-binding; Cell adhesion; Motility/polarity/chemotaxis; Nuclear receptor co-regulator; Oncoprotein; Transcription factor

Chromosomal Location of Human Ortholog: 3p22.1

Cellular Component: adherens junction; basolateral plasma membrane; beta-catenin destruction complex; catenin complex; cell cortex; cell junction; cell-cell adherens junction; centrosome; cytoplasm; cytosol; focal adhesion; intercellular junction; lateral plasma membrane; membrane; nucleoplasm; nucleus; perinuclear region of cytoplasm; plasma membrane; protein complex; transcription factor complex

Molecular Function: alpha-catenin binding; cadherin binding; enzyme binding; estrogen receptor binding; kinase binding; nuclear hormone receptor binding; protein binding; protein C-terminus binding; protein phosphatase binding; SMAD binding; transcription coactivator activity; transcription factor binding

Biological Process: cell adhesion; cell-cell adhesion; epithelial to mesenchymal transition; hair cell differentiation; negative regulation of cell proliferation; negative regulation of mitotic cell cycle, embryonic; negative regulation of protein sumoylation; negative regulation of transcription, DNA-dependent; patterning of blood vessels; positive regulation of apoptosis; positive regulation of histone H3-K4 methylation; positive regulation of interferon type I production; positive regulation of muscle cell differentiation; positive regulation of neuroblast proliferation; positive regulation of neuron apoptosis; positive regulation of transcription factor activity; positive regulation of transcription from RNA polymerase II promoter; positive regulation of transcription, DNA-dependent; proteasomal ubiquitin-dependent protein catabolic process; regulation of angiogenesis; regulation of centriole-centriole cohesion; regulation of fibroblast proliferation; regulation of neurogenesis; regulation of smooth muscle cell proliferation; response to drug; response to estradiol stimulus; stem cell maintenance; Wnt receptor signaling pathway; Wnt receptor signaling pathway through beta-catenin; Wnt receptor signaling pathway, calcium modulating pathway

Disease: Colorectal Cancer; Hepatocellular Carcinoma; Mental Retardation, Autosomal Dominant 19; Ovarian Cancer; Pilomatrixoma
Show more

Precautions

All of MyBioSource's Products are for scientific laboratory research purposes and are not for diagnostic, therapeutics, prophylactic or in vivo use. Through your purchase, you expressly represent and warrant to MyBioSource that you will properly test and use any Products purchased from MyBioSource in accordance with industry standards. MyBioSource and its authorized distributors reserve the right to refuse to process any order where we reasonably believe that the intended use will fall outside of our acceptable guidelines.

Disclaimer

While every efforts were made to ensure the accuracy of the information provided in this datasheet, MyBioSource will not be liable for any omissions or errors contained herein. MyBioSource reserves the right to make changes to this datasheet at any time without prior notice.

It is the responsibility of the customer to report product performance issues to MyBioSource within 30 days of receipt of the product. Please visit our Terms & Conditions page for more information.

Product Note

Select online data sheet information is drawn from bioinformatics databases, occasionally resulting in ambiguous or non-relevant product information. It is the responsibility of the customer to review, verify, and evaluate the information to make sure it matches their requirements before purchasing the kit. Our ELISA Kit assays are dynamic research tools and sometimes they may be updated and improved. If the format of this assay is important to you then please request the current manual or contact our technical support team with a presales inquiry before placing an order. We will confirm the current details of the assay. We cannot guarantee the sample manual posted online is the most current manual, it is intended to serve as an example only. Please refer to the instructions For Use provided with the assay kit for precise details.

Product PubMed Publications

Products associated with anti-CTNNb1 antibody

Pathways associated with anti-CTNNb1 antibody

 Products by Pathway  Pathway Diagram
 Adherens Junction Pathway antibodies  Adherens Junction Pathway Diagram
 Adherens Junction Pathway antibodies  Adherens Junction Pathway Diagram
 Adherens Junctions Interactions Pathway antibodies  Adherens Junctions Interactions Pathway Diagram
 Adipogenesis Pathway antibodies  Adipogenesis Pathway Diagram
 Androgen Receptor Signaling Pathway antibodies  Androgen Receptor Signaling Pathway Diagram
 Apoptosis Pathway antibodies  Apoptosis Pathway Diagram
 Apoptotic Cleavage Of Cell Adhesion Proteins Pathway antibodies  Apoptotic Cleavage Of Cell Adhesion Proteins Pathway Diagram
 Apoptotic Cleavage Of Cellular Proteins Pathway antibodies  Apoptotic Cleavage Of Cellular Proteins Pathway Diagram
 Apoptotic Execution Phase Pathway antibodies  Apoptotic Execution Phase Pathway Diagram
 Arf6 Trafficking Events Pathway antibodies  Arf6 Trafficking Events Pathway Diagram

Diseases associated with anti-CTNNb1 antibody

 Disease Name  Pubmed Publications
 Intestinal Neoplasms Antibodies  >2878 publications with CTNNb1 and Intestinal Neoplasms
 Colorectal Neoplasms Antibodies  >2781 publications with CTNNb1 and Colorectal Neoplasms
 Adenocarcinoma Antibodies  >2505 publications with CTNNb1 and Adenocarcinoma
 Liver Neoplasms Antibodies  >1335 publications with CTNNb1 and Liver Neoplasms
 Colonic Neoplasms Antibodies  >1228 publications with CTNNb1 and Colonic Neoplasms
 Neoplasm Invasiveness Antibodies  >1176 publications with CTNNb1 and Neoplasm Invasiveness
 Adenoma Antibodies  >1138 publications with CTNNb1 and Adenoma
 Carcinoma, Hepatocellular Antibodies  >1119 publications with CTNNb1 and Carcinoma, Hepatocellular
 Breast Neoplasms Antibodies  >1071 publications with CTNNb1 and Breast Neoplasms
 Inflammation Antibodies  >886 publications with CTNNb1 and Inflammation

Organs/Tissues associated with anti-CTNNb1 antibody

 Organ/Tissue Name  Pubmed Publications
 Bone Antibodies  >2310 publications with CTNNb1 and Bone
 Liver Antibodies  >2075 publications with CTNNb1 and Liver
 Blood Antibodies  >1661 publications with CTNNb1 and Blood
 Brain Antibodies  >1651 publications with CTNNb1 and Brain
 Lung Antibodies  >1414 publications with CTNNb1 and Lung
 Embryonic Tissue Antibodies  >1413 publications with CTNNb1 and Embryonic Tissue
 Vascular Antibodies  >1400 publications with CTNNb1 and Vascular
 Muscle Antibodies  >1236 publications with CTNNb1 and Muscle
 Intestine Antibodies  >1158 publications with CTNNb1 and Intestine
 Kidney Antibodies  >1042 publications with CTNNb1 and Kidney